{"id":"dapoxetine-hydrochloride","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Headache"},{"rate":"3-7","effect":"Diarrhea"},{"rate":"3-5","effect":"Insomnia"},{"rate":"1-3","effect":"Syncope"}]},"_chembl":{"chemblId":"CHEMBL2106574","moleculeType":"Small molecule","molecularWeight":"341.88"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dapoxetine works by inhibiting the reuptake of serotonin at the synaptic cleft, thereby increasing serotonin availability in neural pathways that regulate ejaculation. The drug has a rapid onset and short half-life, making it suitable for on-demand dosing prior to sexual activity. Enhanced serotonergic neurotransmission in the brain regions controlling ejaculation results in prolonged time to ejaculation and improved control.","oneSentence":"Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the central nervous system to delay ejaculation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:08:34.449Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Premature ejaculation in men aged 18-64 years"}]},"trialDetails":[{"nctId":"NCT07113145","phase":"PHASE4","title":"Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-06-01","conditions":"Premature (Early) Ejaculation","enrollment":450},{"nctId":"NCT07081659","phase":"PHASE2, PHASE3","title":"On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-03-01","conditions":"Premature (Early) Ejaculation","enrollment":95},{"nctId":"NCT07067970","phase":"NA","title":"Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Medipol University","startDate":"2025-10-01","conditions":"Premature Ejaculation","enrollment":250},{"nctId":"NCT01063881","phase":"PHASE3","title":"The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2010-05-22","conditions":"Sexual Dysfunction, Physiological","enrollment":285},{"nctId":"NCT06425224","phase":"PHASE3","title":"Effectiveness and Safety of TENS Therapy for Premature Ejaculation","status":"RECRUITING","sponsor":"Boston Medical Group","startDate":"2022-06-15","conditions":"Premature Ejaculation, Sex Disorder, TEN","enrollment":129},{"nctId":"NCT04850703","phase":"PHASE1, PHASE2","title":"Brain Networks Implicated in Lifelong Premature Ejaculation Patients","status":"COMPLETED","sponsor":"Moises Domingo","startDate":"2021-02-02","conditions":"Premature Ejaculation, Sexual Dysfunction","enrollment":128},{"nctId":"NCT05556083","phase":"PHASE2","title":"Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2022-10-01","conditions":"Premature Ejaculation","enrollment":200},{"nctId":"NCT03177746","phase":"PHASE4","title":"The Safety of Dapoxetine/Tadalafil Combination Therapy","status":"UNKNOWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2022-12-31","conditions":"Premature Ejaculation, Erectile Dysfunction, Safety Issues","enrollment":40},{"nctId":"NCT04703127","phase":"PHASE3","title":"Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2020-03-30","conditions":"Premature Ejaculation","enrollment":60},{"nctId":"NCT04355949","phase":"NA","title":"Assessment of Serum Levels of Vitamin D, Vitamin B12 and Folic Acid Among Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Treatment.","status":"COMPLETED","sponsor":"Sohag University","startDate":"2020-02-28","conditions":"Vitamin D, Vitamin B12 and Folic Acid Among Patients With Premature Ejaculation","enrollment":60},{"nctId":"NCT04361305","phase":"PHASE3","title":"Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction","status":"UNKNOWN","sponsor":"Yan-Ping Huang","startDate":"2020-06-03","conditions":"Premature Ejaculation, Erectile Dysfunction","enrollment":150},{"nctId":"NCT04085354","phase":"PHASE3","title":"Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation","status":"COMPLETED","sponsor":"Sohag University","startDate":"2019-02-10","conditions":"Premature Ejaculation","enrollment":120},{"nctId":"NCT02572037","phase":"","title":"Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research","status":"COMPLETED","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2015-10","conditions":"Premature Ejaculation","enrollment":568},{"nctId":"NCT02939495","phase":"PHASE4","title":"The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy","status":"COMPLETED","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2016-10","conditions":"Premature Ejaculation, Erectile Dysfunction","enrollment":75},{"nctId":"NCT03583112","phase":"NA","title":"Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients","status":"UNKNOWN","sponsor":"Xidian University","startDate":"2018-07-10","conditions":"Premature Ejaculation","enrollment":100},{"nctId":"NCT02844998","phase":"NA","title":"The Impact and Benefit of Physical Activity on Premature Ejaculation","status":"COMPLETED","sponsor":"Ankara Training and Research Hospital","startDate":"2015-01","conditions":"Premature Ejaculation","enrollment":120},{"nctId":"NCT03018743","phase":"","title":"Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation","status":"UNKNOWN","sponsor":"Pusan National University Hospital","startDate":"2017-01","conditions":"Premature Ejaculation","enrollment":200},{"nctId":"NCT00925457","phase":"","title":"Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2007-03","conditions":"Arrhythmias, Cardiac","enrollment":1608},{"nctId":"NCT02485028","phase":"PHASE1","title":"Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2013-10","conditions":"Drug Interaction Potentiation","enrollment":36},{"nctId":"NCT02485041","phase":"PHASE1","title":"Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2014-11","conditions":"Drug Interaction Potentiation","enrollment":36},{"nctId":"NCT01366664","phase":"PHASE1","title":"A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2011-04","conditions":"Ejaculation","enrollment":24},{"nctId":"NCT01273545","phase":"","title":"PRILIGY Usage Patterns in Selected Populations","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2010-01","conditions":"Sexual Dysfunction, Physiological","enrollment":3000},{"nctId":"NCT01021670","phase":"","title":"An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2009-09","conditions":"Sexual Dysfunction, Physiological, Ejaculation","enrollment":10027},{"nctId":"NCT01928563","phase":"PHASE1","title":"Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine","status":"UNKNOWN","sponsor":"Dong-A Pharmaceutical Co., Ltd.","startDate":"2013-09","conditions":"Healthy Male Subjects","enrollment":24},{"nctId":"NCT01063855","phase":"PHASE3","title":"Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2010-04","conditions":"Erectile Dysfunction, Sexual Dysfunction","enrollment":495},{"nctId":"NCT00210678","phase":"","title":"A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-03","conditions":"Erectile Dysfunction","enrollment":1115},{"nctId":"NCT01419470","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2011-02","conditions":"Premature Ejaculation","enrollment":24},{"nctId":"NCT00210704","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-03","conditions":"Erectile Dysfunction","enrollment":1067},{"nctId":"NCT00229073","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2004-12","conditions":"Erectile Dysfunction","enrollment":1116},{"nctId":"NCT00210613","phase":"PHASE3","title":"A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2004-11","conditions":"Sexual Dysfunction, Ejaculation","enrollment":199},{"nctId":"NCT01230762","phase":"PHASE3","title":"An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"","conditions":"Ejaculation, Erectile Dysfunction, Sexual Dysfunction","enrollment":1774},{"nctId":"NCT00211107","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"2003-06","conditions":"Ejaculation","enrollment":1294},{"nctId":"NCT00211094","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"","conditions":"Ejaculation","enrollment":1320}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS"},{"count":3,"reaction":"ANTINEUTROPHIL CYTOPLASMIC ANTIBODY"},{"count":3,"reaction":"ASTHMA"},{"count":3,"reaction":"COUGH"},{"count":3,"reaction":"ERECTILE DYSFUNCTION"},{"count":3,"reaction":"FEV1/FVC RATIO DECREASED"},{"count":3,"reaction":"FORCED EXPIRATORY VOLUME DECREASED"},{"count":3,"reaction":"FULL BLOOD COUNT ABNORMAL"},{"count":3,"reaction":"HYPERSENSITIVITY"},{"count":3,"reaction":"OBSTRUCTIVE AIRWAYS DISORDER"}],"_approvalHistory":[],"publicationCount":55,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dapoxetine hydrochloride","genericName":"Dapoxetine hydrochloride","companyName":"Janssen Research & Development, LLC","companyId":"johnson-johnson","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the central nervous system to delay ejaculation. Used for Premature ejaculation in men aged 18-64 years.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}